New study from Sylvester Cancer, collaborators shows anti-cancer compound goes beyond current BTK inhibitors Peer-Reviewed Publication UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE “THIS NEW COMPOUND NOT ONLY INHIBITS THE CELLULAR MOLECULE BTK, BUT GOES FURTHER BY TAKING AIM AT THE TARGET AND DESTROYING IT,” SAID Justin Taylor, M.D., SYLVESTER HEMATOLOGIST-RESEARCHER AND THE STUDY’S SENIOR...
Tag: <span>targeting</span>
Post
Finding and targeting a tumor’s sweet spot to eradicate aggressive form of leukemia
by University of Birmingham Credit: Cell Reports (2023). DOI: 10.1016/j.celrep.2023.113568 A highly aggressive common form of leukemia which is activated by mutations in signaling molecules is maintained by a web of regulatory proteins downstream of these signals. New research published in Cell Reports shows that a complex network of interacting genes activated by this altered signaling...